HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea · Delayed Price · Currency is KRW 11,800
+190 (1.64%)
Jun 4, 2026, 1:32 PM KST
HLB Pharmaceutical Market Cap
HLB Pharmaceutical has a market cap or net worth of 163.03 billion as of June 3, 2026. Its market cap has decreased by -44.18% in one year.
Market Cap
163.03B
Enterprise Value
163.48B
Revenue
236.59B
Ranking
n/a
PE Ratio
102.36
Stock Price
11,800.00
Market Cap Chart
Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 163.03B, an increase of 93.44%. That is a compound annual growth rate of 6.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 163.03B | -27.62% |
| Dec 30, 2025 | 225.24B | -33.44% |
| Dec 30, 2024 | 338.42B | 58.45% |
| Dec 28, 2023 | 213.58B | 43.49% |
| Dec 29, 2022 | 148.85B | -21.48% |
| Dec 30, 2021 | 189.57B | -21.05% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyundai Pharmaceutical | 186.55B |
| Whan In Pharm | 186.32B |
| CMG Pharmaceutical | 182.73B |
| JW Lifescience | 175.90B |
| Jeil Pharmaceutical Co.,Ltd | 172.38B |
| Hana Pharm | 169.20B |
| AptaBio Therapeutics | 168.28B |
| Samil Pharmaceutical Co.,Ltd | 157.52B |